High doses of adenotk were injected into the cerebrospinal fluid of rats and nonhuman primates (Macaca mulatta). Vector administration was followed by ganciclovir administration for 14 days. Despite the absence of clinical symptoms, analysis of the cerebrospinal fluid (CSF) and histopathological examination of the central nervous system (CNS) of the monkeys (3 weeks after vector injection) were consistent with a viral meningitis. Immunohistochemical analysis of the inflammatory infiltrates in the monkeys revealed the presence of T and B lymphocytes, indicating a combined cellular and humoral immune response to the vector. This latter was supported by the finding of intrathecal anti-adenovirus antibody synthesis. Rats receiving high intrathecal adenotk doses showed a transient and dose-dependent clinical toxicity consisting of lethargy, hyperemic eyes and weight loss. Histopathological examination of the meninges showed a
Introduction
Without treatment, patients having symptomatic leptomeningeal metastases succumb to their disease 6 to 8 weeks from the initial diagnosis. The use of chemotherapy and/or radiotherapy in the palliative treatment of this fatal neurological illness is limited because of their neurotoxicity. 1 Suicide gene therapy using the thymidine kinase/ganciclovir (TK/GCV) combination is a potential new therapeutical approach in the treatment of this disease. Effectivity of the TK/GCV system in rat leptomeningeal metastases models has been demonstrated for transduced tumor cells, retroviruses, herpes simplex virus type 1 and adenoviral vectors as vehicles to transport the HSVtk gene. [2] [3] [4] [5] In nonhuman primates, intrathecal retrovirus-mediated transfer of HSVtk combined with systemic GCV administration was not associated with significant clinical or histopathological toxicity. 6 However, the only clinical trial was discontinued because of serious toxicity in the first patient (personal communication, EH Oldfield). This toxicity consisted of a severe shift from polymorphonuclear infiltrates during the first postinjection days to clusters of mononuclear cells after 7 days. Acute toxicity is probably related to the early, innate immune response to the vector. In a separate experiment, high levels of IL-8 and IL-6, were measured during the first 2-3 postinjection days in the CSF of two monkeys which received intrathecal adenoLacZ. Therefore, these cytokines seem to play an important role in initiating the nonspecific immune response. In one monkey which received adenotk, recombinant adenovirus was cultured from serum samples obtained at the 7th post-injection day. At this time-point, no vector could be isolated from CSF samples. Based on these preclinical data, we recommend careful dose finding for clinical studies that aim to treat patients with leptomeningeal metastases. Gene Therapy (2000) 7, 1401-1409.
inflammatory reaction and obstruction of the CSF flow caused by clustering cells.
Recombinant adenoviruses have the advantage that high titers can be obtained, obviating the need to inject viral producer cells. Although the immune response to the first generation of adenoviral vectors may limit their use in gene therapy when long-lasting gene expression is required, this immune response may be favourable in cancer gene therapy. 7 We have demonstrated homogeneous distribution along the entire neuraxis and a high transduction efficiency of leptomeningeal cells after intra-cerebrospinal fluid (CSF) injection of adenoLacZ. 8 Preceding clinical trials, in this study we examined the in vivo toxicity of our intra-CSF administered adenoviral vector containing the HSVtk gene (IG.Ad.MLPI.TK) combined with GCV administration in rats and rhesus monkeys. In vivo studies showed a role of TNF-␣, IL-1 and IL-6 in initiating an aspecific early immune response. 9, 10 In vitro studies also suggest a critical role of adenovirus-induced IL-8 production in eliciting an innate immune response against the vector. 11, 12 In two nonhuman primates, cytokine production (IL-8 and IL-1, IL-2, IL-6, TNF-␣ and IFN-␥) in the CSF was determined 24, 48 and 72 h after intrathecal adenolacZ injection. a Titers in infectious units/ml. RM5 and RM6 received 7.4 × 10 9 IU adenolacZ, RM7 and RM8 7.6 × 10 10 IU adenotk.
Results

Rhesus monkeys
Clinical observations: After intraventricular or suboccipital vector injection (Table 1) all four rhesus monkeys recovered rapidly from the procedure and general anesthesia.
The first 24 h after vector injection they showed a decreased food intake. The general condition during the experiment was good. Body temperature was within the normal range. 13 No detectable neurological or behavioral abnormalities were seen. At the end of the experiment however, the adenotk-treated animals showed a 13% reduction in body weight.
Titers in CSF:
Vector titers were determined in samples of lumbar CSF and are summarized in Table 2 . Within the first post-injection day, a rapid decline of the titers was observed. However, after 72 h low titers could still be detected.
Cell count in CSF:
In RM7 and RM8, CSF was sampled for cell counts. Vector injection resulted in CSF pleiocytosis, reflecting an inflammatory reaction (Table 3) . We observed a shift from granulocytes in the first 3 postinjection days to a predominance of mononuclear cells after 7 days. The non-bacterial nature of the initial polymorphonuclear pleiocytosis was supported by negative CSF cultures for aerobic and anaerobic bacteria.
Hematological/biochemical parameters: Apart from a mild increase in ALAT (RM7 74 U/l and RM8 48 U/l, normal value 0-31 U/l) and LDH (RM7 886 U/l and RM8 1002 U/l, normal value 146-423 U/l) at day 7 no hematological or biochemical abnormalities were found in either of the two animals. At day 14 all laboratory values were within normal range.
Antibodies: IgG anti-adenovirus antibody titers were determined in CSF and serum of the two animals that lived for 3 weeks (RM7 and RM8) and are summarized in Table 4 . Both animals showed an increase in serum and CSF titers. Synthesis of specific anti-adenovirus antibodies within the CSF compartment was demonstrated using the formula: CSF (anti-Ad IgG) titer (reciprocal) × total serum IgG/total CSF IgG × serum (anti-Ad IgG) titer.
14 Viral shedding: All cultures for recombinant adenovirus of urine and stool samples and pharyngeal swabs cultures collected at days 1 to 5 from RM7 and RM8 were negative. In both animals adenotk was cultured from serum collected 24 h after injection of the vector. Adenotk was also cultured from a serum sample of RM7 which was collected 7 days after vector administration. At this time-point no virus was cultured from CSF samples of this animal. The presence of adenotk and absence of wildtype adenovirus in positive cultures was confirmed by PCR ( Figure 1) .
No adenolacZ was cultured from serum samples of RM5 and RM6 taken at days 1 to 3.
Neuropathological examination: Gross examination of brain, spinal cord and meninges was normal in all four animals. However, microscopical examination of the CNS of both monkeys treated with a high dose of adenotk revealed inflammatory changes (Figure 2 ). The intraventricularly injected animal (RM7) had infiltrates of the choroid plexus in the lateral ventricles. The infiltrates consisted mainly of lymphocytes, plasma cells and histiocytic cells. Focally, the inflammatory cells invaded the superficial layer of the parenchyma resulting in the loss of some ependymal cells. We observed the same histopathological changes in the choroid plexus and wall of the fourth ventricle. Focal mononuclear infiltrates of the arachnoid covering the medulla oblongata and brain stem were seen. The infiltrates of the arachnoid were associated with superficial infiltration of the dura mater. The amount of mononuclear cells in the leptomeninges decreased with increasing distance to the injection site.
No signs of hydrocephalus were observed. The neuropathological findings in the suboccipitally injected animal (RM8) were essentially the same as in RM7. Less infiltration of the choroid plexus in the lateral ventricles was found. In this animal, however, the choroid plexus of the fourth ventricle (close to the injection site) was more extensively infiltrated with mononuclear cells. In addition some gliosis of the parenchyma around the aquaduct was observed.
Only mild inflammatory infiltrates consisting of both mononuclear and polynuclear cells were observed in the two animals that received adenoLacZ.
Immunohistochemistry: The inflammatory infiltrates were further analyzed by immunohistochemistry ( Figure 3 ). Immunohistochemical staining shows that the mononuclear leukocytic infiltrates of the choroid plexus mainly consist of T lymphocytes (CD3 + ), partly being of the CD4 + subtype. Although it is probable that a significant part of the CD3 + lymphocytes consisted of CD8 + cells we have not been able to prove this. Neither of the anti-CD8
+ antibodies that we used (cross) reacted with nonhuman primate CD8
+ antigen (which is also true for the positive Gene Therapy Cytokines: In a separate experiment, two animals (RM5 and RM6, Table 1 ) received adenoLacZ. Cytokine levels in the CSF and serum were determined 24, 48 and 72 h after vector administration. High levels of IL-6 and IL-8 were measured in CSF samples obtained at 24 and 48 h. After 72 h, a low level of IL-2 could be detected in RM6 (Table 5) . A transient mild increase of serum TNF-␣ was measured at days 1 and 2. At days 1-3, high serum (but not CSF) levels of IL-1␤ and IFN-␥ were measured in the intraventricularly injected animal, possibly reflecting procedure-related effects.
Figure 2 HE staining of the brain and spinal cord of RM7. Inflammatory infiltrate of the choroid plexus in the lateral ventricle, the site of vector administration (A). Focal mononuclear infiltrates are seen in the leptomeninges (B) and folded dura mater (C) covering the convexity of the brain. At the cervical level of the spinal cord no histopathological changes are observed (D)
.
Rats
Clinical observations in rats: Rats receiving high doses of adenotk developed clinical signs within the first 24 h after injection (Table 6 ). Signs consisted of lethargy, hyperemic eyes and weight loss and were dose-dependent. The hyperemic eyes resulted from lack of cleaning as a consequence of the lethargy. The animals that received 5.0 × 10 9 IU of adenotk demonstrated the most severe toxicity. Two of 27 rats in this high-dose group died within 14 h after vector administration. These animals died at night and their tissues were already autolytic when they were found and processed for histological examination. No clinical signs were observed in any of the animals that received 6.3 × 10 8 IU or less. Signs were transient, lasting 2-4 days and somewhat more prolonged (5-6 days) in animals that received the combination of adenotk and ganciclovir. After 2-3 weeks, the weight of the animals was comparable with controls.
Neuropathological examination: Twenty-four hours after suboccipital administration of 5 × 10 9 IU adenotk inflammatory infiltrates of predominantly polymorphonuclear cells were seen, especially located in the choroid plexus of the fourth ventricle (near the injection site, Figure 4) . Related to the inflammation, in the arachnoid, some scattered foci of extravasated erythrocytes were observed. At the surface of the brain and around the spinal cord a few focal polymorphonuclear infiltrates were present. Histopathology of the animals killed at day 2 was comparable with the pathology of the rats killed 24 hours after vector injection. However, animals killed at day 7 showed less extensive inflammatory infiltrates. At this time-point the infiltrates mainly consisted of mononuclear cells. After 16 days just a few scattered foci of mononuclear cells were detected near the fourth ventricle and in the leptomeninges of brain and spinal cord. In these animals, no inflammation of the choroid plexus could be observed. In rats in which, accidentally, the medulla oblongate was punctured, gliosis around the needle tract was visible. No neuropathological difference could be detected between rats that received ganciclovir and those that had not received ganciclovir.
Histopathological examination of the central nervous system of the two rats out of the highest dose group that died soon after vector injection, revealed a massive subarachnoid hemorrhage extending into the ventricles. In one rat a prepontine localized intraparenchymal hematoma was observed. Also, leukocytic infiltrates were present. However, due to the autolysis, discrimination between procedure-related death or lethal vector-induced toxicity was not possible. In summary, in the acute phase pronounced polymorphonuclear infiltrates were present. Within a week we observed a shift to less extensive mononuclear infiltrates and after 2 weeks only very mild neuropathological changes remained.
Discussion
After intra-CSF injection of adenotk combined with systemic ganciclovir administration in nonhuman primates, CSF analysis and neuropathological findings were consistent with a viral meningitis. Immunohistochemical analysis of the mononuclear inflammatory infiltrates revealed CD3
+ T lymphocytes, partly of the CD4 + subtype, and CD20 + B cells indicating an adaptive immune response. We also found intrathecal synthesis of antiadenovirus antibody that is probably explained by the pronounced focal clusters of CD20 + B cells. In Fischer rats, intrathecal injection of high doses of adenotk resulted in transient, dose-dependent clinical toxicity. Histopathological examination of the CNS of these animals showed a shift from pronounced polymorphonuclear infiltrates at the first post-injection days to less extensive mononuclear infiltrates at day 7. Sixteen days after virus injection only mild neuropathological changes were present, consistent with a near total recovery.
In two rhesus monkeys, analysis of chemokines involved in the early, innate immune response, revealed high levels of Il-6 and IL-8 in the CSF (but not in serum)
Gene Therapy 24 and 48 h after vector administration with much lower levels of these cytokines after 72 h.
The immune response to adenoviral vectors may limit the duration of transgene expression, contributes to in vivo toxicity and displays a biphasic pattern consisting of an early innate response and an adaptive T cell-mediated phase. In peripheral organs, the early innate phase is characterized by the presence of polymorphonuclear leukocytes; after intracerebral injection of adenoviral vectors mononuclear cells predominate. [15] [16] [17] [18] [19] Comparable with peripheral organs, we found after intra-CSF administration an early phase response mainly consisting of polymorphonuclear cells. This nonspecific early response may be elicited by particle-induced release of proinflammatory cytokines and chemoattractants. After intrapulmonary administration of a recombinant adenoviral vector both in a mouse model and in a clinical trial, elevated levels of TNF-␣, IL-1 and IL-6 were measured. 9, 20 In vitro experiments suggested a critical role for adenovirusinduced production of the chemotactic cytokine IL-8.
11,12
The presence of polymorphonuclear cells in the CSF of the monkeys and the early infiltrates consisting of polymorphonuclear cells in rats after intra-CSF administration of adenotk also suggest an important in vivo role of IL-8.
Recently, Cartmell et al 10 showed that IL-1 is an important mediator of the innate early immune response to adenovirus in the brain. In rats, IL-1 synthesis (and not TNF-␣), was associated with the rise in body temperature observed within a few hours following intraventricular recombinant adenovirus administration. This IL-1 production may precede the synthesis of IL-8 and IL-6 which we measured in the nonhuman primates at days 1-3. Otherwise, it is possible that a concomitant production of IL-1 and IL 8 follows vector administration. It is less likely that IL-6 acts as a mediator of the febrile response to intraventricular injected adenoviral vectors as suggested by Cartmell et al. We measured high IL-6 levels in the CSF of the monkeys 24 and 48 h after injection that were not associated with an increase in body temperature.
The adaptive or T cell-mediated phase of the anti-adenoviral immune response is most likely elicited by the concomitant response to adenoviral and transgene encoded foreign proteins. 7, [21] [22] [23] [24] [25] Based on their experiments, Byrnes et al 26 found that most of the inflammation was directed against viral proteins rather than the transgene. However, viral replication or de novo protein synthesis seem not to be a prerequisite for induction of a cellular immune response. 27 In our rat study, the presence of an adaptive immune response was demonstrated by the shift from polymorphonuclear cells to mononuclear cells in the CSF and in the inflammatory infiltrates of the choroid plexus and leptomeninges. In rhesus monkeys, 3 weeks after intra-CSF administration of adenotk an abundance of T lymphocytes was still present in the choroid plexus infiltrates. The humoral part of the adaptive immune response was demonstrated by the presence of B cell clusters combined with the specific intrathecal antiadenoviral antibody synthesis. These results indicate that the administration of a recombinant adenovirus into the CSF elicits a strong immune response. Indeed, although the CNS is considered 'immune-privileged', administration of antigens and viruses into the CSF provoke an adaptive immune response that is probably mediated by antigenic presentation in the deep cervical lymph nodes, followed by trafficking of antigen-specific T and B cells to the CNS compartment. [28] [29] [30] [31] [32] [33] In a previous study we have demonstrated transgene expression in a cervical lymph node of a rhesus monkey after intra-CSF injection of adenoLacZ, indicating that this route of antigenic presentation is also true for (adeno)viral vectors. 8 In this study, we also demonstrated higher antibody titers after intrathecal as compared with intravenous and intranasal vector administration in rats, once again indicating that the immune privilege of the CSF compartment is limited.
Unlike other previous studies, including ours, Dewey et al 34 reported persistent brain inflammation and demyelination after successful treatment of CNS-1 tumors in rats using the adenotk/ganciclovir combination. This unexpected finding underlines the complexity of the immune response to intra-CNS administered adenoviral vectors and indicates that clinical trials should be performed with great care.
We demonstrated the presence of adenotk in the serum of the monkeys 24 h after injection of the vector. In one of the animals (RM8) recombinant adenovirus was cultured from serum collected at day 7. Most likely some viral particles survived after transduction of lymphocytes or macrophages within or near the CNS. An alternative explanation for the late positive culture may be low-level replication. The high levels of IL-6 may result in replication of recombinant adenoviruses by enhancement of cellular activity substituting for the E1A protein. 35 However, this explanation is unlikely because the IL-6 levels peaked at days 1 and 2 after vector injection. Moreover, the high CSF levels were measured only in the CSF while the recombinant vector was cultured at day 7 from the serum and not from the CSF of this animal.
In conclusion, intra-CSF administration of adenotk in rats resulted in a dose-dependent clinical toxicity that was reversible in all but two animals. After 2 weeks, only minimal neuropathological abnormalities remained.
Despite the absence of clinical signs in the monkeys, the CSF findings and the neuropathological changes after 3 weeks clearly showed a viral meningitis and indicated a strong immune response against the vector. When longlasting gene expression is required, immunomodulating strategies and the use of less immunogenic adenoviral vectors are necessary. In treatment of patients with leptomeningeal metastases the induction of an immune response may be favorable when directed against the tumor. At present, it is unknown how the neuropathological findings in the monkeys relate to clinical symptoms (such as headache and nausea) which can be found in patients with viral meningitis. Thus, in clinical studies careful dose finding, starting at low doses, is strongly recommended.
Materials and methods
Viral constructs
Recombinant adenoviruses harboring the HSVtk gene (IG.Ad.MLPI.TK, adenotk) were made from plasmid pMLP.TK in which HSVtk expression is driven by the adenovirus-derived major late promoter and transcription is terminated by the SV40 polyadenylation signal. The generation of HSVtk is described elsewhere. 36 The vector used in this experiment, IG.Ad.MLPI.TK is similar to the previously described IG.Ad.MLP.TK except that it has an extended deletion of the E1 region (⌬E1 459-3510), removing all E1 protein coding sequences from the vector. Furthermore, 71 nucleotides of 3Ј untranslated lacZ sequences present in IG.Ad.MLP.TK due to cloning procedures were removed in IG.Ad.MLPI.TK. Otherwise, the vectors were similar as judged by expression levels of tk, production yields and pIX protein synthesis in E1 complementing cell lines (data not shown). Recombinant viruses were generated by cotransfecting E1 complementing cells with SalI linearized pMLPI.TK and the large ClaI fragment of wild-type Ad5 DNA. Recombinant viruses were plaque-purified twice, propagated and titrated according to standard procedures. 37 Virus titers were determined by end point titration on 911 cells. Titer of IG.Ad.MLPI.TK used in this experiment was 7.6 × 10 10 IU/ml with a particle/IU ratio of 11.8. Replicationcompetent adenovirus was less than 1:2.5 × 10 9 . Virus diluent was 5% sucrose in PBS. The batch was tested for the presence of endotoxin using the Limulus Amebocyte Lysate assay (BioWhittaker, Walkersville, MD, USA) and was found to contain Ͻ3 Endotoxin Units/dose. Generation of IG.Ad.CMV.LacZ (adenoLacZ) is described elsewhere. 5 
Virus titers in cerebrospinal fluid
The titers of the virus in the cerebrospinal fluid samples were determined (in duplo) by end point titration on 911 cells as previously described. 38 
Shedding
The presence of virus in urine and stool samples and pharyngeal swabs was tested by culture on 293 and Hep2 indicator cells. 39 After 2 and 5 days incubation, the cells were assayed for the presence of recombinant adenovirus by indirect immunofluorescence using the genus-specific monoclonal antibody MAd-g1 (isotype, IgG 2a ). 40 The presence of adenotk or adenoLacZ in serum was determined by infecting an E1 complementing cell line (PER C6/911) with 25-100 l of the serum samples. To rule out contamination with wild-type adenovirus A549 cells were infected with the same samples. In cases where virus could be cultured it was further analyzed using PCR to detect tk sequences and to discriminate between adenotk and wild-type adenovirus. For PCR analysis, virus and cells were harvested (centrifugation, 1500 r.p.m. for 15 min) and the pellets were resuspended in 100 l PBS mix (containing 1 l prot K (20 mg/ml), 1 l RNAse (20 mg/ml) and 50 l 10% SDS per 1 ml PBS) and stored at −20°C.
The primer oligonucleotides used for tk detection were TK8 (5Ј-CATACCGACGATCTGCGAC; Gibco BRL, Rockville, MD, USA) and Ad5-2 (5Ј-GGAGGCTGC AGTCTCCAACGGCGT; Isogen Bioscience, Amsterdam, The Netherlands). Primers TK8 and Ad5-2 amplify a 513 bp from IG.Ad.MLPI.TK. The presence of wild-type adenovirus sequences were detected by primer oligonucleotides AM-1 (5Ј-CCGTTACGTGGAGACTCGCC), Ea-1 (5Ј-CGTGTAGTGTATTTATACCCG) and Ea-2 (5Ј-TCGTCACTGGGTGAAAGCCA) obtained from Isogen Bioscience. These primers amplify a 591 bp fragment from wtAd5 DNA. The PCR reaction mixture contained 5 l 10× Supertaq buffer, 1 l 10 mm dNTPs, 1 l 1 nm primer I, 1 l 1 nm primer II, 0.1 l Taq polymerase and 5 l of 50× diluted DNA sample. The PCR cycle (35 cycles) used for TK8 and Ad5-2 was 94°C for 30 s, 50°C for 30 s, 72°C for 60 s, and for AM1 and Ea2 94°C for 30 s, 60°C for 30 s and 72°C for 60 s. The PCR reactions were preceded by 94°C for 1 min and finished by 72°C for 10 min.
Cytokines IL-8, IL-6, IL2, IL-1, TNF-␣ and IFN-␥ were determined in CSF of the monkeys by ELISA. The ELlSAs were performed at the Department of Immunology of the Biomedical Primate Research Center, Rijswijk, The Netherlands. Levels of IL-1␤, IL-6 and IL-8 were measured using human cytokine kits crossreacting with rhesus monkey cytokines (PeliKine-compact; CLB, The Netherlands). Anti-IL-2 monoclonal antibody (BG-5, Diaclone, Besançon, France) was used for coating and polyclonal antiHuIL-2 (U-CyTech, Utrecht, The Netherlands) as detector antibody for determination of IL-2. Coating for TNF-␣ ELISA was QS-Tc and detector antibody was 61E71 (UCyTech). IFN-␥ was detected by using a crossreacting antihuman IFN-␥ ELISA kit (U-CyTech).
In short, wells of a 96-well flat-bottomed ELISA plate were filled with 35 l of coating solution and 65 l of PBS was added to reach a volume of 100 l. Plates were incubated for 1 h at 37°C. Subsequently, the wells were washed extensively with PBS/Tween and filled with 200 l 2% BSA (in PBS) and incubated for 1 h at 37°C. After emptying the wells they were filled with appropriate dilutions of the test samples in PBS containing 1% BSA (100 l per well) and incubated for 2 h at 37°C in a humidified atmosphere. After rinsing the wells with PBS/Tween, 100 l of the appropriate concentration of biotinylated detector antibodies were added followed by incubation for 1 h at 37°C. Then the wells were extensively washed with PBS/Tween followed by the addition of 100 l of goat anti-biotine antibodies and incubation for another hour at 37°C. After washing, substrate conversion was monitored at 405 nm.
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Antibodies to adenovirus Antibodies to adenovirus were determined by complement fixation assay (before treatment and at day 20 (Diagnostic Center SSDZ, Delft, The Netherlands)). IgG antibodies to adenovirus were determined by indirect ELISA (Department of Virology, University Hospital Rotterdam, The Netherlands). Intrathecal antibody synthesis was calculated using the formula: CSF (anti-Ad IgG) titer (reciprocal) × total serum IgG/total CSF IgG × serum (anti-Ad IgG) titer. Specific anti-adenovirus antibody synthesis within the CSF compartment is indicated by a value greater than 1. 14 
Immunohistochemistry
Immunohistochemistry was performed on 5-m sections. The slides were deparaffinized and endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol, followed by preincubation with 5% normal goat serum (Dako, Glostrup, Denmark) diluted in phosphate-buffered saline and bovine serum albumin (PBS-BSA) for 15 min at 37°C. Primary antibodies were used reacting with CD45 + (leukocytes), CD3 + (pan-T cell), CD4 + (T helper/suppressor) and CD20 + (B cells) cells (Dako). The sections were preincubated with the indicated amounts of the antibodies for 1 h at RT followed by incubation with biotinylated goat anti-rabbit antibody or biotinylated rat anti-mouse antibody (Dako), diluted 1:400 in PBS, for 30 min. Next, the sections were incubated with either streptavidin-biotin-alkaline phosphatase or streptavidin-biotin-peroxidase complex (Dako) for 30 min followed by substrate revelation (Vector Laboratories, Burlingame, CA, USA). Between the steps, the sections were washed 3 × 5 min in PBS. The slides were lightly counterstained with hematoxylin.
Animals and surgical procedures
All animal experiments were approved by the Institutional Animal Care and Use Committee. During the experiment the animals were housed under D-II containment.
Rats: Male Fischer rats, weighing 180-300 g were anesthetized with ether and fixed in a stereotactic frame. Suboccipital injection of virus or control substance (PBS) was performed as described by Vincent et al. 5 Rhesus monkeys: Two adult rhesus monkeys (Macaca mulatta); one male (RM7) and one female (RM8), were treated (Table 1) . No antibodies to adenovirus were detected in the sera of these monkeys before treatment and hematological and biochemical parameters were within the normal range. The surgical procedure was performed under aseptic conditions. The animal which received the vector intraventricularly (RM7) was sedated with ketamine (10 mg/kg, i.m.) followed by general inhalational anesthesia with 1% isoflurane. A stereotactic frame (David Kopf Instruments, Tajunga, CA, USA) was used to fix the skull of the monkey. Using a dentist's drill, a 3-mm hole was made into the skull 18 mm anterior to the intra-aural line and 1-2 mm right to the midline. After electrocoagulation of the dura mater, a blunted 26-gauge spinal needle was inserted to a depth of 25 mm related to the upper margin of the skull. 41, 42 The location of the needle in the right lateral ventricle was confirmed by the observation of CSF pulsations in the sodium chlor-ide containing needle. Virus was injected over a 5-min period and was followed by flushing of the needle with NaCl 0.9%. The needle was slowly withdrawn over a 1-2-min period. In addition, intraventricular administration of the virus was confirmed by a high titer of recombinant adenovirus (Ͼ10 8 IU/ml) in the suboccipital CSF sample that was taken 3 h after the injection. The suboccipital (RM8) puncture was performed using a 22-gauge spinal needle. In brief, the needle was inserted in the midline just above the spine of the atlas. When the needle struck the occiput it was being depressed a little allowing penetration of the dura just below the base of the occiput. 43 Before virus injection 1 ml CSF was tapped. After vector administration the needle was flushed with 0.5 ml normal saline. In a previous article we showed an equal distribution of the vector after intraventricular and suboccipital administration in nonhuman primates. Therefore, it is unlikely that these routes of vector administration influence the outcome of the experiment. 8 
Experimental design
Rhesus monkeys: Both monkeys received 7.6 × 10 10 IU (= 9.0 × 10 11 particles) IG.Ad.MLPI.TK, in a volume of 1 ml, into the CSF. Forty-eight hours after virus injection, ganciclovir (GCV) was administered intravenously for 14 days (10 mg/kg/day, in 100 ml normal saline). For GCV administration, the animals were sedated daily (ketamin) and during a 30-min period the drug was slowly infused via one of the limb veins. The animals were checked daily to assess general condition, body temperature and weight. Special attention was paid to neurological status and behavior. From day 1 to day 5, daily urine and stool samples and pharyngeal swabs were cultured to assess viral shedding. Blood samples taken on days 7 and 14 were tested for hemogram, liver enzymes and renal functions. Neutralizing antibodies to adenovirus were determined in serum and CSF samples on days 7, 14 and 20. Virus titers in CSF were determined in CSF samples on days 1, 2, 3 and 7. The presence of recombinant adenovirus in blood was determined in blood samples taken at days 1, 7 and 14 by culturing and PCR as described above. In addition, at day 7, CSF samples of both monkeys were cultured in Thioglucolate medium and Triplicase Soy Broth (Becton Dickinson, Franklin Lakes, NJ, USA) to detect the presence of anaerobic and aerobic bacteria. At day 20, the animals were killed by an overdose of pentobarbital. Total body fixation was performed by perfusion of 1 liter PBS followed by 1 liter 4% formalin. Brain and spinal cord were removed and postfixed in 4% formalin for 1 week. After paraffin embedding, 10 and 5 m coronal sections of the brain and spinal cord were cut and stained with hematoxylin and eosin or used for immunohistochemistry.
In a separate experiment, cytokines were determined in the CSF of two other rhesus monkeys (RM5 and RM6) before, 24, 48 and 72 h after intra-CSF administration of 7.4 × 10 9 IU adenoLacZ.
Rats: All rats received vector or control substance (PBS) in a volume of 50 l. Groups and amounts of recombinant adenovirus injected are summarized in Table 6 . Forty-eight hours after vector administration four rats received ganciclovir for 14 days (15 mg/kg, twice a day).
Rats were killed at days 1, 2, 7 and 16 and were perfused via the left cardiac ventricle with PBS followed by formalin 4%. Skull and vertebral column were removed en bloc and postfixed in formalin 4% for 24-48 h. Subsequently, skull and spinal cord were decalcified in Kristensen solution for 4-6 weeks. After decalcification and paraffin embedding, brain and spinal cord (including meninges and the covering bony parts) were cut into 5-m sections and stained with hematoxylin/eosin.
